Skip to main content
LigaChem Biosciences Inc. logo

LigaChem Biosciences Inc. — Investor Relations & Filings

Ticker · 141080 ISIN · KR7141080002 KO Professional, scientific and technical activities
Filings indexed 295 across all filing types
Latest filing 2023-12-14 Notice of Dividend Amou…
Country KR South Korea
Listing KO 141080

About LigaChem Biosciences Inc.

https://ligachembio.com/

LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative medicines. Leveraging its core expertise in medicinal chemistry, the company focuses on developing Antibody-Drug Conjugates (ADCs), immuno-oncology drugs, and small molecules. A key asset is its proprietary, next-generation ADC platform technology, engineered to overcome the limitations of conventional ADC technologies. The company's pipeline includes multiple programs targeting oncology, as well as other therapeutic areas such as antibiotics and anti-fibrotics. LigaChem Biosciences actively pursues global drug development through strategic partnerships, including co-development and licensing agreements with international pharmaceutical companies.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the shareholder register in preparation for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the record date. Given it is a regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2023-12-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity (in this case, the National Pension Service) crosses a significant ownership threshold in a listed company (LegoChem Biosciences). This falls under the category of Major Shareholding Notification.
2023-12-01 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for LegoChem Biosciences, covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, company overview, capital changes, and business operations, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status via Trust Agreement' (신탁계약등에의한취득상황보고서) filed by LegoChem Biosciences. It details the company's purchase of its own shares through a trust contract with Mirae Asset Securities. This type of filing, which reports the company's buyback activity, falls under the category of 'Transaction in Own Shares'.
2023-10-04 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Annual Report' (사업보고서) of LegoChem Biosciences. It contains detailed financial data, including consolidated financial statement notes, liquidity analysis, and management's discussion of financial results. While it is a correction, it functions as a comprehensive financial report update containing substantive financial data, which aligns with the definition of an Annual Report (10-K) or a significant financial filing update. Given the depth of the financial data provided, it is classified as an Annual Report (10-K). FY 2022
2023-08-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by Quad Investment Management in LegoChem Biosciences. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant share ownership levels.
2023-08-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.